FIA
ARKG icon

Foundations Investment Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Foundations Investment Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,286
Closed -$212K – 842
2024
Q3 		$212K Sell
8,286
-717
-8% -$18.3K ﹤0.01% 757
2024
Q2 		$211K Sell
9,003
-450
-5% -$11.4K 0.01% 710
2024
Q1 		$272K Sell
9,453
-2,587
-21% -$77.8K 0.01% 601
2023
Q4 		$350K Sell
12,040
-2,867
-19% -$78K 0.01% 517
2023
Q3 		$415K Sell
14,907
-48,643
-77% -$1.59M 0.01% 432
2023
Q2 		$2.17M Sell
63,550
-3,753
-6% -$118K 0.07% 184
2023
Q1 		$2.02M Sell
67,303
-4,256
-6% -$132K 0.07% 163
2022
Q4 		$2.02M Sell
71,559
-3,029
-4% -$96.1K 0.08% 130
2022
Q3 		$2.45M Sell
74,588
-6,855
-8% -$252K 0.11% 82
2022
Q2 		$2.88M Sell
81,443
-1,586
-2% -$55.5K 0.12% 79
2022
Q1 		$3.52M Sell
83,029
-4,846
-6% -$231K 0.14% 62
2021
Q4 		$4.69M Buy
87,875
+8,681
+11% +$600K 0.18% 51
2021
Q3 		$5.76M Buy
79,194
+3,658
+5% +$307K 0.25% 34
2021
Q2 		$6.8M Buy
+75,536
New +$6.42M 0.33% 38

Other funds holding ARKG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Foundations Investment Advisors's ARKG Position: Q4 2024 in Review

Foundations Investment Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 8,286 shares — an estimated $212K sold.

Foundations Investment Advisors first reported a position in ARKG in Q2 2021 and held it in 14 quarters. The position peaked at $6.8M in Q2 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

  • Foundations Investment Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
  • Foundations Investment Advisors sold 8,286 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $212K.
  • Foundations Investment Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 14 quarters.
  • Foundations Investment Advisors's ARK Genomic Revolution ETF position peaked at $6.8M in Q2 2021.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Foundations Investment Advisors's 13F filing for Q4 2024, filed 22 Jan 2025.